Permission was obtained from the Ministry of Health of the Russian Federation to conduct three Phase III clinical trials to assess the efficacy and safety of a new oral medicine for patients with moderate or severe Crohn's disease, sponsored by the pharmaceutical company Selgene, Switzerland.

Congratulations to the AMAM Study team on the successful completion of the audit of the sponsor of the pharmaceutical company Eli Lilly!

Successfully passed the visit of the selection center to participate in three clinical trials for the treatment of ulcerative colitis, sponsored by the pharmaceutical company Pfizer

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen